REFERENCES

• WittchenHU.JacobiF.Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies.Eur Neuropsychopharmacoi.2005154357376
   PubMed Web of Science ®Google Scholar
• NuttD.ArgyropoulosS.HoodS.PotokarJ.Generalized anxiety disorder: a comorbid disease.Eur Neuropsychopharmacoi.200616suppl 2S109S118
   PubMedGoogle Scholar
• RobergeP.Normand-LauziereF.RaymondI.et alGeneralized anxiety disorder in primary care: mental health services use and treatment adequacy.BMC Earn Pract.201516146
   PubMed Web of Science ®Google Scholar
• BuoliM.CaldiroliA.CalettiE.et alNew approaches to the pharmacological management of generalized anxiety disorder.Expert Opin Pharmacother,201314217518423282069
   PubMed Web of Science ®Google Scholar
• BandelowB.ZoharJ.HollanderE.et alWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.World J Biol Psychiatry.20089424831218949648
   PubMed Web of Science ®Google Scholar
• PollackMH.Refractory generalized anxiety disorder.J Clin Psychiatry.200970suppl 23238
   PubMedGoogle Scholar
• StarcevicV.Generalized anxiety disorder: psychopharmacotherapy update on a common and commonly overlooked condition.Australas Psychiatry.201523433834226023165
   PubMed Web of Science ®Google Scholar
• EtkinA.PraterKE.SchatzbergAF.et alDisrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.Arch Gen Psychiatry.200966121361137219996041
   PubMed Web of Science ®Google Scholar
• MakovacE.MeetenF.WatsonDR.et alNeurostructural abnormalities associated with axes of emotion dysregulation in generalized anxiety.Neuroimage Clin.20151017218126759791
   PubMed Web of Science ®Google Scholar
• SchienleA.EbnerF.SchaferA.Localized gray matter volume abnormalities in generalized anxiety disorder.Eur Arch Psychiatry Clin Neurosci.2011261430330720820793
   PubMed Web of Science ®Google Scholar
• LiaoM.YangF.ZhangY.et alLack of gender effects on gray matter volumes in adolescent generalized anxiety disorder.J Affect Disord.201415527828224262640
   PubMed Web of Science ®Google Scholar
• LiaoM.YangF.ZhangY.et alChildhood maltreatment is associated with larger left thalamic gray matter volume in adolescents with generalized anxiety disorder.PLoS One.201388e7189823951265
   PubMed Web of Science ®Google Scholar
• StrawnJR.WehryAM.ChuWJ.et alNeuroanatomic abnormalities in adolescents with generalized anxiety disorder: a voxel-based morphometry study.Depress Anxiety.201330984284823495075
   PubMed Web of Science ®Google Scholar
• StrawnJR.WegmanJohn C.DominickKC.et alCortical surface anatomy in pediatric patients with generalized anxiety disorder.J Anxiety Disord.201428771772325155256
   PubMed Web of Science ®Google Scholar
• HilbertK.PineDS.MuehlhanM.et alGray and white matter volume abnormalities in generalized anxiety disorder by categorical and dimensional characterization.Psychiatry Res.2015234331432026490569
   PubMed Web of Science ®Google Scholar
• MoonCM.JeongGW.Abnormalities in gray and white matter volumes associated with explicit memory dysfunction in patients with generalized anxiety disorder.Acta Radiol.201758335336127273376
   PubMed Web of Science ®Google Scholar
• MoonCM.JeongGW.Alterations in white matter volume and its correlation with clinical characteristics in patients with generalized anxiety disorder.Neuroradiology.201557111127113426293129
   PubMed Web of Science ®Google Scholar
• AbdallahCG.CoplanJD.JackowskiA.et alA pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD.Eur Neuropsychopharmacoi.2013234276284
   PubMed Web of Science ®Google Scholar
• CanuE.KosticM.AgostaF.et alBrain structural abnormalities in patients with major depression with or without generalized anxiety disorder comorbidity.J Neurol.201526251255126525794861
   PubMed Web of Science ®Google Scholar
• TrompDP.GrupeDW.OathesDJ.et alReduced structural connectivity of a major frontolimbic pathway in generalized anxiety disorder.Arch Gen Psychiatry.201269992593422945621
   PubMed Web of Science ®Google Scholar
• MonkCS.TelzerEH.MoggK.et alAmygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder.Arch Gen Psychiatry.200865556857618458208
   PubMed Web of Science ®Google Scholar
• McClureEB.AdlerA.MonkCS.et alfMRI predictors of treatment outcome in pediatric anxiety disorders.Psychopharmacology (Berl).200719119710516972100
   PubMed Web of Science ®Google Scholar
• RoyAK.FudgeJL.KellyC.et alIntrinsic functional connectivity of amygdala-based networks in adolescent generalized anxiety disorder.J Am Acad Child Adolesc Psychiatry.201352329029923452685
   PubMed Web of Science ®Google Scholar
• NitschkeJB.SarinopoulosI.OathesDJ.et alAnticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response.Am J Psychiatry.2009166330231019122007
   PubMed Web of Science ®Google Scholar
• EtkinA.PraterKE.HoeftF.et alFailure of anterior cingulate activation and connectivity with the amygdala during implicit regulation of emotional processing in generalized anxiety disorder.Am J Psychiatry.2010167554555420123913
   PubMed Web of Science ®Google Scholar
• HolzelBK.HogeEA.GreveDN.et alNeural mechanisms of symptom improvements in generalized anxiety disorder following mindfulness training.Neuroimage Clin.2013244845824179799
   PubMed Web of Science ®Google Scholar
• YassaMA.HazlettRL.StarkCE.Hoehn-SaricR.Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder.J Psychiatr Res.20124681045105222575329
   PubMed Web of Science ®Google Scholar
• BlairK.ShaywitzJ.SmithBW.et alResponse to emotional expressions in generalized social phobia and generalized anxiety disorder: evidence for separate disorders.Am J Psychiatry.200816591193120218483136
   PubMed Web of Science ®Google Scholar
• PaulesuE.SambugaroE.TortiT.et alNeural correlates of worry in generalized anxiety disorder and in normal controls: a functional MRI study.Psychol Med.201040111712419419593
   PubMed Web of Science ®Google Scholar
• WeinbergA.OlvetDM.HajcakG.Increased error-related brain activity in generalized anxiety disorder.Biol Psychol.201085347248020883743
   PubMed Web of Science ®Google Scholar
• PalmME.ElliottR.McKieS.et alAttenuated responses to emotional expressions in women with generalized anxiety disorder.Psychol Med.20114151009101820716396
   PubMed Web of Science ®Google Scholar
• BlairKS.GeraciM.SmithBW.et alReduced dorsal anterior cingulate cortical activity during emotional regulation and top-down attentional control in generalized social phobia, generalized anxiety disorder, and comorbid generalized social phobia/generalized anxiety disorder.Biol Psychiatry.201272647648222592057
   PubMed Web of Science ®Google Scholar
• BallTM.RamsawhHJ.Campbell-SillsL.et alPrefrontal dysfunction during emotion regulation in generalized anxiety and panic disorders.Psychol Med.20134371475148623111120
   PubMed Web of Science ®Google Scholar
• MoonCM.YangJC.JeongGW.Explicit verbal memory impairments associated with brain functional deficits and morphological alterations in patients with generalized anxiety disorder.J Affect Disord.201518632833626277269
   PubMed Web of Science ®Google Scholar
• ChaJ.GreenbergT.CarlsonJM.et alCircuit-wide structural and functional measures predict ventromedial prefrontal cortex fear generalization: implications for generalized anxiety disorder.J Neurosci.201434114043405324623781
   PubMed Web of Science ®Google Scholar
• ChaJ.CarlsonJM.DedoraDJ.et alHyper-reactive human ventral tegmental area and aberrant mesocorticolimbic connectivity in overgeneralization of fear in generalized anxiety disorder.J Neurosci.201434175855586024760845
   PubMed Web of Science ®Google Scholar
• MonkCS.NelsonEE.McClureEB.et alVentrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder.Am J Psychiatry.200616361091109716741211
   PubMed Web of Science ®Google Scholar
• EtkinA.SchatzbergAF.Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders.Am J Psychiatry.2011168996897821632648
   PubMed Web of Science ®Google Scholar
• SchlundMW.VerduzcoG.CataldoMF.Hoehn-SaricR.Generalized anxiety modulates frontal and limbic activation in major depression.Behav Brain Funct.20128822321875
   PubMed Web of Science ®Google Scholar
• WangW.HouJ.QianS.et alAberrant regional neural fluctuations and functional connectivity in generalized anxiety disorder revealed by resting-state functional magnetic resonance imaging.Neurosci Lett.2016624788427163197
   PubMed Web of Science ®Google Scholar
• MakovacE.MeetenF.WatsonDR.et alAlterations in amygdalaprefrontal functional connectivity account for excessive worry and autonomic dysregulation in generalized anxiety disorder.Biol Psychiatry.2016801078679526682467
   PubMed Web of Science ®Google Scholar
• ChenAC.EtkinA.Hippocampal network connectivity and activation differentiates post-traumatic stress disorder from generalized anxiety disorder.Neuropsychopharmacology.201338101889189823673864
   PubMed Web of Science ®Google Scholar
• StrawnJR.BitterSM.WeberWA.et alNeurocircuitry of generalized anxiety disorder in adolescents: a pilot functional neuroimaging and functional connectivity study.Depress Anxiety.2012291193994722628125
   PubMed Web of Science ®Google Scholar
• CuiH.ZhangJ.LiuY.et alDifferential alterations of resting-state functional connectivity in generalized anxiety disorder and panic disorder.Hum Brain Mapp.20163741459147326800659
   PubMed Web of Science ®Google Scholar
• LiuWJ.YinDZ.ChengWH.et alAbnormal functional connectivity of the amygdala-based network in resting-state FMRI in adolescents with generalized anxiety disorder.Med Sci Monit.20152145946725673008
   PubMed Web of Science ®Google Scholar
• WhalenPJ.JohnstoneT.SomervilleLH.et alA functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder.Biol Psychiatry .200863985886317964548
   PubMed Web of Science ®Google Scholar
• NitschkeJB.SarinopoulosI.OathesDJ.et alAnticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response.Am J Psychiatry.2009166330231019122007
   PubMed Web of Science ®Google Scholar
• MaslowskyJ.MoggK.BradleyBP.et alA preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder.J Child Adolesc Psychopharmacol.201020210511120415605
   PubMed Web of Science ®Google Scholar
• FonzoGA.RamsawhHJ.FlaganTM.et alCognitive-behavioral therapy for generalized anxiety disorder is associated with attenuation of limbic activation to threat-related facial emotions.J Affect Disord.2014169768525171782
   PubMed Web of Science ®Google Scholar
• BrownGG.OstrowitzkiS.SteinMB.et alTemporal profile of brain response to alprazolam in patients with generalized anxiety disorder.Psychiatry Res.2015233339440126211623
   PubMed Web of Science ®Google Scholar
• Hoehn-SaricR.SchlundMW.WongSH.Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder.Psychiatry Res.20041311112115246451
   PubMed Web of Science ®Google Scholar
• WuJC.BuchsbaumMS.HersheyTG.et alPET in generalized anxiety disorder.Biol Psychiatry.19912912118111991888800
   PubMed Web of Science ®Google Scholar
• MaronE.KuikkaJT.UlstK.et alSPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder.Eur Arch Psychiatry Clin Neurosci.2004254639239615538601
   PubMed Web of Science ®Google Scholar
• LeeLT.TsaiHC.ChiMH.et alLower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study.IntClin Psychopharmacol.2015303175178
   PubMed Web of Science ®Google Scholar
• TiihonenJ.KuikkaJ.RasanenP.et alCerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis.Mol Psychiatry.1997264634719399689
   PubMed Web of Science ®Google Scholar
• MathewSJ.MaoX.CoplanJD.et alDorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging study.Am J Psychiatry.200416161119112115169704
   PubMed Web of Science ®Google Scholar
• MathewSJ.PriceRB.ShunguDC.et alA pilot study of the effects of chronic paroxetine administration on hippocampal W-acetylaspartate in generalized anxiety disorder.J Psychopharmacol.20102481175118119204062
   PubMed Web of Science ®Google Scholar
• MathewSJ.PriceRB.MaoX.et alHippocampal Ai-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.Biol Psychiatry.200863989189818028881
   PubMed Web of Science ®Google Scholar
• MoonCM.KangHK.JeongGW.Metabolic change in the right dorsolateral prefrontal cortex and its correlation with symptom severity in patients with generalized anxiety disorder: proton magnetic resonance spectroscopy at 3 Tesla.Psychiatry Clin Neurosci.201569742243025611853
   PubMed Web of Science ®Google Scholar
• HettemaJM.PrescottCA.KendlerKS.A population-based twin study of generalized anxiety disorder in men and women.J Nerv Ment Dis.2001189741342011504317
   PubMed Web of Science ®Google Scholar
• MatherL.BlomV.BergstromG.SvedbergP.An underlying common factor, influenced by genetics and unique environment, explains the covariation between major depressive disorder, generalized anxiety disorder, and burnout: a Swedish twin study.Twin Res Hum Genet.201619661962727620693
   PubMed Web of Science ®Google Scholar
• TadicA.RujescuD.SzegediA.et alAssociation of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.Am J Med Genet B Neuropsychiatr Genet2003117B516
   Google Scholar
• YouJS.HuSY.ChenB.ZhangHG.Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder.Psychiatr Genet.2005151711
   Web of Science ®Google Scholar
• MolinaE.CervillaJ.RiveraM.et alPolymorphic variation at the serotonin 1-A receptor gene is associated with comorbid depression and generalized anxiety.Psychiatr Genet.201121419520121512427
   PubMed Web of Science ®Google Scholar
• MoreiraFP.FabiaoJD.BittencourtG.et alThe Met allele of BDNF Val66Met polymorphism is associated with increased BDNF levels in generalized anxiety disorder.Psychiatr Genet.201525520120726110341
   PubMed Web of Science ®Google Scholar
• WangY.ZhangH.LiY.et alBDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.J Affect Disord.201518671226209750
   PubMed Web of Science ®Google Scholar
• AmstadterAB.KoenenKC.RuggieroKJ.et alNPY moderates the relation between hurricane exposure and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults.Depress Anxiety.201027327027520037921
   PubMed Web of Science ®Google Scholar
• KoenenKC.AmstadterAB.RuggieroKJ.et alRGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults.Depress Anxiety.200926430931518833580
   PubMed Web of Science ®Google Scholar
• GragnoliC.Proteasome modulator 9 gene SNPs, responsible for antidepressant response, are in linkage with generalized anxiety disorder.J Cell Physiol.201422991157115924648162
   PubMed Web of Science ®Google Scholar
• ChenSD.SunXY.NiuW.et alCorrelation between the level of microRNA expression in peripheral blood mononuclear cells and symptomatology in patients with generalized anxiety disorder.Compr Psychiatry.20166921622427423364
   PubMed Web of Science ®Google Scholar
• WingoAP.GibsonG.Blood gene expression profiles suggest altered immune function associated with symptoms of generalized anxiety disorder.Brain Behavlmmun.201543184191
   Web of Science ®Google Scholar
• CooperAJ.NarasimhanS.RickelsK.LohoffFW.Genetic polymorphisms in the PACAP and PAC1 receptor genes and treatment response to venlafaxine XR in generalized anxiety disorder.Psychiatry Res.201321031299130023972788
   PubMed Web of Science ®Google Scholar
• CooperAJ.RickelsK.LohoffFW.Association analysis between the A118G polymorphism in the 0PRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.Hum Psychopharmacol.201328325826223658070
   PubMed Web of Science ®Google Scholar
• LohoffFW.NarasimhanS.RickelsK.Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.PharmacogenomicsJ.2013135464469
   Web of Science ®Google Scholar
• NarasimhanS.AquinoTD.MultaniPK.et alVariation in the catecholO-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.Psychiatry Res.2012198111211522417933
   PubMed Web of Science ®Google Scholar
• LohoffFW.AquinoTD.NarasimhanS.et alSerotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.PharmacogenomicsJ.20131312126
   Web of Science ®Google Scholar
• NarasimhanS.AquinoTD.HodgeR.et alAssociation analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorder.Neurosci Lett.2011503320020221889574
   PubMed Web of Science ®Google Scholar
• PerlisRH.FijalB.DhariaS.HoustonJP.Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder.Pharmacogenomics J.201313328028522249355
   PubMed Web of Science ®Google Scholar
• SaungWT.NarasimhanS.LohoffFW.Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder.Hum Psychopharmacol.201429431632124723432
   PubMed Web of Science ®Google Scholar
• BandelowB.BaldwinD.AbelliM.et alBiological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.World J Biol Psychiatry.201615153
   Google Scholar
• InyLJ.PecknoldJ.Suranyi-CadotteBE.et alStudies of a neurochemical link between depression, anxiety, and stress from PHjimipramine and PHjparoxetine binding on human platelets.Biol Psychiatry.19943652812917993954
   PubMed Web of Science ®Google Scholar
• HernandezE.LastraS.UrbinaM.et alSerotonin, 5-hydroxyindoleacetic acid and serotonin transporter in blood peripheral lymphocytes of patients with generalized anxiety disorder.Int Immunopharmacol.20022789390012188031
   PubMed Web of Science ®Google Scholar
• GerraG.ZaimovicA.ZambelliU.et alNeuroendocrine responses to psychological stress in adolescents with anxiety disorder.Neuropsychobiology.2000422829210940763
   PubMed Web of Science ®Google Scholar
• VreeburgSA.ZitmanFG.van PeltJ.et alSalivary cortisol levels in persons with and without different anxiety disorders.Psychosom Med.201072434034720190128
   PubMed Web of Science ®Google Scholar
• PhillipsAC.BattyGD.GaleCR.et alMajor depressive disorder, generalised anxiety disorder, and their comorbidity: associations with cortisol in the Vietnam Experience Study.Psychoneuroendocrinology.201136568269020952132
   PubMed Web of Science ®Google Scholar
• SeddonK.MorrisK.BaileyJ.et alEffects of 7.5% CO2 challenge in generalized anxiety disorder.J Psychopharmacol.2011251435120233897
   PubMed Web of Science ®Google Scholar
• AlfanoCA.ReynoldsK.ScottN.et alPolysomnographic sleep patterns of non-depressed, non-medicated children with generalized anxiety disorder.J Affect Disord.20131471-337938423026127
   PubMed Web of Science ®Google Scholar
• MantellaRC.ButtersMA.AmicoJA.et alSalivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder.Psychoneuroendocrinology.200833677378118407426
   PubMed Web of Science ®Google Scholar
• HekK.DirekN.NewsonRS.et alAnxiety disorders and salivary cortisol levels in older adults: a population-based study.Psychoneuroendocrinology.201338230030522776419
   PubMed Web of Science ®Google Scholar
• HoodSD.MelicharJK.TaylorLG.et alNoradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge.J Psychopharmacol.2011251788620093317
   PubMed Web of Science ®Google Scholar
• TafetGE.FederDJ.AbulafiaDP.RoffmanSS.Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder.Cogn Affect Behav Neurosci.200551374015913006
   PubMed Web of Science ®Google Scholar
• LenzeEJ.MantellaRC.ShiP.et alElevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.Am J Geriatr Psychiatry.201119548249020808146
   PubMed Web of Science ®Google Scholar
• CohnJB.WilcoxCS.MeltzerHY.Neuroendocrine effects of buspirone in patients with generalized anxiety disorder.Am J Med.1986803B3640
   PubMed Web of Science ®Google Scholar
• KleinE.Zinder0.ColinV.et alClinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.Acta Psychiatr Scand .19959263994088837965
   PubMed Web of Science ®Google Scholar
• MolendijkML.BusBA.SpinhovenP.et alGender specific associations of serum levels of brain-derived neurotrophic factor in anxiety.World J Biol Psychiatry.201213753554321888560
   PubMed Web of Science ®Google Scholar
• PallantiS.TofaniT.ZanardelliM.et alBDNF and Artemin are increased in drug-naive non-depressed GAD patients: preliminary data.IntJ Psychiatry Clin Pract.201418425526024994477
   PubMed Web of Science ®Google Scholar
• BallS.MarangellLB.LipsiusS.RussellJM.Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.Prog Neuropsychopharmacoi Biol Psychiatry.201343217221
   PubMed Web of Science ®Google Scholar
• Jockers-ScherublMC.ZubraegelD.BaerT.et alNerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder.Prog Neuropsychopharmacoi Biol Psychiatry.2007311200204
   PubMed Web of Science ®Google Scholar
• BankierB.BarajasJ.Martinez-RumayorA.JanuzziJL.Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients.Eur Heart J.200829182212221718603621
   PubMed Web of Science ®Google Scholar
• CopelandWE.ShanahanL.WorthmanC.et alGeneralized anxiety and C-reactive protein levels: a prospective, longitudinal analysis.Psychol Med.201242122641265022716910
   PubMed Web of Science ®Google Scholar
• TofaniT.MannelliLD.ZanardelliM.et alAn immunologic profile study in drug-naive generalized anxiety non depressed patients: a pilot study.Eur Neuropsychopharmacoi.201525suppl 2S226
   Google Scholar
• KohKB.LeeBK.Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders.Psychosom Med.19986044794839710294
   PubMed Web of Science ®Google Scholar